Literature DB >> 15501378

Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?

Clara E Dismuke1, Michael T French, Helena J Salomé, Mark A Foss, Chris K Scott, Michael L Dennis.   

Abstract

Previous economic studies have examined the association between substance abuse treatment and reduced costs to society, but it remains uncertain whether the economic measures used in cost and benefit-cost analyses of treatment programs correspond in direction and magnitude with clinical outcomes. In response to this uncertainty, the present study analyzed a longitudinal data set of addiction treatment clients to determine the statistical agreement between clinical and economic outcomes over time. Data were collected from 1,326 clients in the Chicago cohort of the Persistent Effects of Treatment Study. These individuals were interviewed at baseline as well as at 6-, 24-, 36-, and 48-month followup periods (91.6% followup). Correlations between clinical and economic measures were generally small (rho of 0.1 to 0.3) and often became non-significant once we controlled for baseline severity. The results demonstrate that although some associations exist, outcomes should be evaluated along both clinical and economic dimensions.

Mesh:

Substances:

Year:  2004        PMID: 15501378     DOI: 10.1016/j.jsat.2004.08.005

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  6 in total

1.  Cost-effectiveness of public sector substance abuse treatment: comparison of a managed care approach to a traditional public sector system.

Authors:  Martha C Beattie; Teh-Wei Hu; Rui Li; Jason C Bond
Journal:  J Behav Health Serv Res       Date:  2005 Oct-Dec       Impact factor: 1.505

2.  Substance use, education, employment, and criminal activity outcomes of adolescents in outpatient chemical dependency programs.

Authors:  Ana I Balsa; Jenny F Homer; Michael T French; Constance M Weisner
Journal:  J Behav Health Serv Res       Date:  2007-12-07       Impact factor: 1.505

3.  Medical and Mental Health Status Among Drug Dependent Patients Participating in a Smoking Cessation Treatment Study.

Authors:  Jennifer E Lima; Malcolm S Reid; Jennifer L Smith; Yulei Zhang; Huiping Jiang; John Rotrosen; Edward Nunes
Journal:  J Drug Issues       Date:  2009-03

4.  Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care.

Authors:  Anirban Basu
Journal:  J Health Econ       Date:  2011-04-23       Impact factor: 3.883

5.  State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.

Authors:  Hefei Wen; Janet R Cummings; Jason M Hockenberry; Laura M Gaydos; Benjamin G Druss
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

6.  Social costs of robbery and the cost-effectiveness of substance abuse treatment.

Authors:  Anirban Basu; A David Paltiel; Harold A Pollack
Journal:  Health Econ       Date:  2008-08       Impact factor: 3.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.